We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

94 hedge funds and large institutions have $287M invested in Rigel Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86% less call options, than puts

Call options by funds: $399K | Put options by funds: $2.79M

Holders
94
Holders Change
+94
Holders Change %
–
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
94
Increased
–
Reduced
–
Closed
–
Calls
$399K
Puts
$2.79M
Net Calls
-$2.39M
Net Calls Change
-$2.39M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
51
ProShare Advisors
Maryland
$241K +$326K +7,203 New
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$233K +$316K +6,980 New
TD Asset Management
53
TD Asset Management
Ontario, Canada
$225K +$305K +6,740 New
PIM
54
Platinum Investment Management
Australia
$224K +$305K +6,730 New
MCM
55
Munder Capital Management
Michigan
$223K +$302K +6,663 New
RFC
56
Russell Frank Company
Washington
$217K +$296K +6,522 New
JP Morgan Chase
57
JP Morgan Chase
New York
$213K +$289K +6,372 New
AIG
58
American International Group
New York
$196K +$266K +5,874 New
Jane Street
59
Jane Street
New York
$190K +$258K +5,700 New
BA
60
BlackRock Advisors
Delaware
$177K +$240K +5,287 New
Bank of America
61
Bank of America
North Carolina
$170K +$231K +5,091 New
WMSA
62
Weiss Multi-Strategy Advisers
New York
$167K +$227K +5,000 New
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$163K +$221K +4,872 New
Citadel Advisors
64
Citadel Advisors
Florida
$160K +$217K +4,784 New
Citigroup
65
Citigroup
New York
$140K +$190K +4,204 New
Barclays
66
Barclays
United Kingdom
$139K +$187K +4,138 New
WB
67
WesBanco Bank
West Virginia
$134K +$181K +4,000 New
Principal Financial Group
68
Principal Financial Group
Iowa
$134K +$182K +4,011 New
Public Employees Retirement Association of Colorado
69
Public Employees Retirement Association of Colorado
Colorado
$127K +$173K +3,810 New
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$127K +$173K +3,816 New
Morgan Stanley
71
Morgan Stanley
New York
$118K +$161K +3,550 New
SCA
72
SAC Capital Advisors
Connecticut
$114K +$155K +3,420 New
Prudential Financial
73
Prudential Financial
New Jersey
$100K +$136K +3,001 New
California Public Employees Retirement System
74
California Public Employees Retirement System
California
$97K +$132K +2,910 New
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$96.7K +$131K +2,895 New
1 2
3
4

RIGL Hedge Fund Activity: Q2 2013 in Review

94 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2013, worth a combined $287M.

Buyers outnumbered sellers: 94 funds opened new RIGL positions and 0 closed out — a net gain of 94 holders — while 0 added to existing stakes and 0 trimmed.

  • 94 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $287M of Rigel Pharmaceuticals stock for Q2 2013.
  • 94 funds opened new Rigel Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +94 holders.

Based on aggregated 13F filings for Q2 2013.